by Sean Hutchinson | Feb 4, 2025 | UK
Background It is a fundamental principle of patent laws around the world that, in return for being granted a patent for an invention, the patent applicant must disclose the invention to the public in a manner sufficiently clear and complete for a person skilled in the...
by Juliette Boynton | Jan 27, 2025 | EPO
This issue was previously considered by the Enlarged Board in G3/04, who concluded that the Appeal could not be continued. The G3/04 decision notes that the status of an intervener is defined in Article 105 EPC which states:- Any third party may, in accordance with...
by David Eyre | Dec 6, 2024 | Uncategorised
Haemophilia B A blot clot is produced following a cascade of reactions after injury. Haemophilia is a disorder of blood clotting whereby one of the factors that contributes to this cascade of reactions is defective. Consequently, for sufferers from this condition...
by Sean Hutchinson | Nov 21, 2024 | Uncategorised
Doctrine of Equivalents In a recent decision, the US Court of Appeals for the Federal Circuit has confirmed the importance of explaining why two features are equivalent when alleging that a patent is infringed under the so-called “doctrine of equivalents”. The...
by Chloe Sullivan | Nov 14, 2024 | UPC
Background The multi-territory dispute between NanoString and 10x Genomics, which has been ongoing in the US and Europe for quite some time, was expanded to the Unified Patent Court soon after it opened its doors in June last year. The battle before the UPC began in...
Recent Comments